This is a great webinar, thanks for sharing. Clearly there is a...

This is a great webinar, thanks for sharing. Clearly there is a major issue globally about how to classify and treat cannabis from a regulatory perspective, the case Tamir spoke of with regards to the efficacy of cannabis vs opiates for a terminal patient that gave him 5 weeks of pain relief without the stultifying effects of opiates is proof in action - and in support of Tommy Huppert's comments, we need the testing and data to underpin this clear evidence. With strong research and data, I am confident that long term we will view the legalisation of cannabis (both medicinal and recreational) as a logical step and companies such as IHL whom will contribute to this research, will not just profit and grow but genuinely provide improved patient outcomes. It therefore becomes a moral imperative to support the efforts of IHL to my mind. All in MYHO only - good luck to all.
Cheers Hoffy